跳至主要内容
临床试验/TCTR20211130002
TCTR20211130002招募中不适用

Incidence of Erythrocytosis in Patients Receiving Kidney Transplantation and Predictive Factors in Siriraj Hospital

Siriraj Hospital Mahidol University0 个研究点目标入组 400 人开始时间: 2021年11月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • 1.The patients aged 18 years and older who received kidney transplant at Siriraj Hospital between January 1, 2010 and December 31, 2020.
  • 2.The patients who were diagnosed with thrombocytopenia after kidney transplantation.
  • - Male: hemoglobin level greater than 16.5 g/dl or hematocrit greater than 49%
  • - Female: hemoglobin level greater than 16 g/dl or hematocrit level The value was greater than 48 percent,
  • 3.The patients received continued follow-up at a kidney transplant clinic for at least 1 year.

排除标准

  • 1.The Patients diagnosed with thrombocytopenia prior to kidney transplantation
  • - Male: hemoglobin level greater than 16.5 g/dl or hematocrit level greater than 49%
  • - Female: hemoglobin level greater than 16 g/dl or hematocrit level More than 48 percent
  • 2.The Patients with Leukocytosis
  • 3.The Patients who have received organ transplants other than kidneys.
  • 4.The Patients receiving medication erythropoietin stimulating agents or testosterone drugs.
  • 5.The Patients with a history of lung or heart disease.
  • 6.The Patients with a history of obstructive sleep apnea at the time of thrombosis.

研究者

发起方
Siriraj Hospital Mahidol University

相似试验